Navigation Links
Rising Australian biotech stars set to connect on the world stage
Date:3/27/2008

Two of Australias leading life scientists have been chosen from a highly competitive field of candidates to take part in an initiative by Merck Sharp & Dohme and Advance to boost the capability of the countrys burgeoning biopharmaceutical industry.

Antisense Therapeutics Ltd (ASX code: ANP) Research Director Dr Christopher Wraight and DendriMed Research Director Dr Raisa Monteiro have been selected as joint winners of the 2008 Advancing BioBusiness Award, which aims to expand vital global connections for Australian science and foster more international business for local life sciences companies.

They will attend the worlds largest biotechnology meeting, the Biotechnology Industry Organisation (BIO) international convention in Boston in May, which attracts over 22,000 visitors.

A tailored program of meetings will also be scheduled with leading American organisations and individuals including venture capital firms, research institutes, biotechnology entrepreneurs and biopharmaceutical companies. This will help build valuable international networks, knowledge and collaborations that will benefit their business and the Australian industry.

The Advancing BioBusiness Award is an innovative scheme by Merck Sharp & Dohme and Advance, a dynamic, diverse global community of Australian professionals overseas committed to advancing Australia and Australians.

Senator Kim Carr, Minister for Innovation, Industry, Science and Research, said:

"The Advancing BioBusiness Award complements the Rudd Government's policy of promoting innovation and commercialisation in the biotechnology and pharmaceutical sector, encouraging closer links between Australian biotech and global pharmaceutical companies, and helping Australian biotechs access global supply chains."

Dr Phil Kearney, Merck Sharp & Dohmes manager for external scientific affairs, said Australia is recognised for its excellence in medical research and its vigorous and creative biopharmaceutical industry. However the number of drug development projects which reach advanced clinical development is only a quarter of what would be predicted on the basis of our output in scientific literature.

By immersing two of our top biopharmaceutical people in successful commercial research centres in the United States, and providing them with opportunities to share their learning back at home, we aim to build a stronger Australian capability to win in this highly competitive global knowledge market, he said.


'/>"/>

Contact: Jackie Crossman
jackie@crossmancommunications.com.au
61-293-630-288
Research Australia
Source:Eurekalert

Related medicine news :

1. New HIV diagnoses rising in New York City among young men who have sex with men
2. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
3. Disabilities Rising Among Workers; Need for Employer-Driven Disability Awareness, Support Efforts Also Increases
4. Spectrum of Eating Disorders - from Anorexia to Obesity - are Cause for Rising Concern among K-12 Students and Educators
5. Obesity Driving Rising U.S. Health Costs
6. Survey of Iowa Voters Reveals Surprising Results and Attitudes Toward Americas Health Care Crisis
7. Asymptomatic peripheral artery disease prevalence is rising
8. Independent Review Organizations Poised to Help Reduce Rising Healthcare Cost
9. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
10. Surprising New Research Indicates that Significant Numbers of Children as Young as 11 are Engaging in Sexual Activity and that Dating Violence and Abuse are Part of Their Relationships
11. Successful Massachusetts Healthcare Reform Initiative Faces Rising Healthcare Costs in Year Two
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2016)... (PRWEB) , ... May 01, 2016 , ... Good Circle ... in need of chiropractic help. The agency offers a verity of health, life and ... need. According to Chris Nelson at the firm, “Many insurance plans don’t cover chiropractic ...
(Date:4/30/2016)... ... April 30, 2016 , ... Saturday, April 30, marks World ... on public health. The World Veterinary Association (WVA) and the World Organization for ... continuing education with a One Health focus, which emphasizes how veterinarians pursue continuing ...
(Date:4/29/2016)... ... April 30, 2016 , ... ... products, announces the Pick Up Springboard, an automotive invention that improves the storage ... industry is worth $162 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic ... the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain ... mood optimization products to the store is just one more way Shamangelic Healing ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... student loans more flexibility in repaying their loans, more information about their loan ... time when total outstanding student loan debt, including federal and private loans, has ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... the development of oral drug delivery systems, announced today that ... presented by Joseph Gunnar & Co. LLC, taking ... . Nadav Kidron , CEO of Oramed, will ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... 28, 2016 TapImmune,Inc. (TPIV), ... peptide and gene-based immunotherapeutics and vaccines for the treatment of ... at the 3rd Annual Growth Capital Expo to ... 2016 at Caesars Palace in Las Vegas, Nevada.  The ... May 4 th by Dr. John N. Bonfiglio ...
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
Breaking Medicine Technology: